Isabella Presch MD MBA
@isabellapresch.bsky.social
Medical Executive | Clinical Research | Medical Affairs | rare diseases | Advanced Therapies | pediatrics
Reposted by Isabella Presch MD MBA
#PrecisionMedicine is moving fast. See what is next at #ASH25 as Dr. Sophie Zaaijer shows how genetic diversity drives stronger discovery. Register now: https://ow.ly/Mekn50Xs1oc
#HemeSky #MedSky #ASHinaFlash
#HemeSky #MedSky #ASHinaFlash
November 15, 2025 at 2:02 PM
#PrecisionMedicine is moving fast. See what is next at #ASH25 as Dr. Sophie Zaaijer shows how genetic diversity drives stronger discovery. Register now: https://ow.ly/Mekn50Xs1oc
#HemeSky #MedSky #ASHinaFlash
#HemeSky #MedSky #ASHinaFlash
Reposted by Isabella Presch MD MBA
It’s Friday, I’m in love.
November 14, 2025 at 6:41 PM
It’s Friday, I’m in love.
Reposted by Isabella Presch MD MBA
Weekend long read, anyone? The @fwf-at.bsky.social features IMBA Scientific Director Elly Tanaka in a new article that lays out how she pioneered research in regeneration biology, bringing axolotls as a model organism to the molecular era.
November 14, 2025 at 10:44 AM
Weekend long read, anyone? The @fwf-at.bsky.social features IMBA Scientific Director Elly Tanaka in a new article that lays out how she pioneered research in regeneration biology, bringing axolotls as a model organism to the molecular era.
Another amazing opportunity to engage with the fabulous rare diseases community comes to a close. encouraging meeting stakeholders working together bringing innovative treatments to people living with rare conditions ✨the future is bright
@fortrea.bsky.social @fortreatrials.bsky.social
@fortrea.bsky.social @fortreatrials.bsky.social
October 29, 2025 at 2:55 PM
Another amazing opportunity to engage with the fabulous rare diseases community comes to a close. encouraging meeting stakeholders working together bringing innovative treatments to people living with rare conditions ✨the future is bright
@fortrea.bsky.social @fortreatrials.bsky.social
@fortrea.bsky.social @fortreatrials.bsky.social
Last day starting with an inspiring panel discussion about how new technologies can be leveraged for smarter decision making in #raredisease #drugdevelopment #access #innovation #WODCEU25 #AI
October 29, 2025 at 8:10 AM
Last day starting with an inspiring panel discussion about how new technologies can be leveraged for smarter decision making in #raredisease #drugdevelopment #access #innovation #WODCEU25 #AI
#WODC2025 inspiring key note about Europe‘s life science strategy ✨
#innovation #research #takeda #norgine #europeancommission #eurordis
#innovation #research #takeda #norgine #europeancommission #eurordis
October 28, 2025 at 8:41 AM
#WODC2025 inspiring key note about Europe‘s life science strategy ✨
#innovation #research #takeda #norgine #europeancommission #eurordis
#innovation #research #takeda #norgine #europeancommission #eurordis
October 27, 2025 at 11:30 AM
Thrilled to be #WODC25 starting with an important topic: innovative methodologies to accelerate rare diseases drug development #ERDERA #raredisease #patientcentricity
October 27, 2025 at 9:14 AM
Thrilled to be #WODC25 starting with an important topic: innovative methodologies to accelerate rare diseases drug development #ERDERA #raredisease #patientcentricity
Reposted by Isabella Presch MD MBA
New @nejm.org
One-shot gene therapy for a type of congenital deafness enabled some children to hear for the first time, and 3 of 12 kids achieved normal hearing
www.nejm.org/doi/full/10.1056/NEJMoa2400521
One-shot gene therapy for a type of congenital deafness enabled some children to hear for the first time, and 3 of 12 kids achieved normal hearing
www.nejm.org/doi/full/10.1056/NEJMoa2400521
DB-OTO Gene Therapy for Inherited Deafness | NEJM
Genetic deficiency of otoferlin, a protein critical to synaptic transmission by the sensory hair cells of the ear, causes congenital deafness. Medicines to treat the condition are lacking; children...
www.nejm.org
October 12, 2025 at 2:19 PM
New @nejm.org
One-shot gene therapy for a type of congenital deafness enabled some children to hear for the first time, and 3 of 12 kids achieved normal hearing
www.nejm.org/doi/full/10.1056/NEJMoa2400521
One-shot gene therapy for a type of congenital deafness enabled some children to hear for the first time, and 3 of 12 kids achieved normal hearing
www.nejm.org/doi/full/10.1056/NEJMoa2400521
Reposted by Isabella Presch MD MBA
🤖🩸 #ArtificialIntelligence in everyday clinical practice: A study by #MedUniVienna shows that language models sometimes provide better answers than experts when it comes to questions about #venousthromboembolism. ⬇️
📰 Results in @jthjournal.bsky.social
📰 Results in @jthjournal.bsky.social
Artificial intelligence on a par with thrombosis experts
Learn more about the potential and limitations of language models in everyday clinical practice!
www.meduniwien.ac.at
October 7, 2025 at 1:39 PM
🤖🩸 #ArtificialIntelligence in everyday clinical practice: A study by #MedUniVienna shows that language models sometimes provide better answers than experts when it comes to questions about #venousthromboembolism. ⬇️
📰 Results in @jthjournal.bsky.social
📰 Results in @jthjournal.bsky.social
Reposted by Isabella Presch MD MBA
🚀 AI vs. Thrombosis Experts: Who performs better?
New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases.
@nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social
New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases.
@nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social
Large language models versus thrombosis experts: A comparative study on patient education and clinical decision-making in venous thromboembolism
Large language models (LLMs) have demonstrated remarkable capabilities in various
medical fields, yet their performance in thrombosis and haemostasis, particularly
in patient education and complex cli...
www.jthjournal.org
September 29, 2025 at 9:06 PM
🚀 AI vs. Thrombosis Experts: Who performs better?
New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases.
@nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social
New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases.
@nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social
Reposted by Isabella Presch MD MBA
We just learned about a 3rd dimension of how Covid can affect our arteries.
erictopol.substack.com/p/covid-and-...
erictopol.substack.com/p/covid-and-...
Covid and Our Arteries
A new study on acceleration of vascular aging adds to the body of evidence
erictopol.substack.com
August 18, 2025 at 10:07 PM
We just learned about a 3rd dimension of how Covid can affect our arteries.
erictopol.substack.com/p/covid-and-...
erictopol.substack.com/p/covid-and-...
Reposted by Isabella Presch MD MBA
Ready for the next #Haemcast? Coming this Thursday, @katekhair.bsky.social looks back on Terence O'Rourke's reflections on life with severe haemophilia and how #haemophilia care has and hasn't changed. https://loom.ly/A4UWu6M
#HemeSky #BloodSky #MedSky #podcast
#HemeSky #BloodSky #MedSky #podcast
July 29, 2025 at 7:01 AM
Ready for the next #Haemcast? Coming this Thursday, @katekhair.bsky.social looks back on Terence O'Rourke's reflections on life with severe haemophilia and how #haemophilia care has and hasn't changed. https://loom.ly/A4UWu6M
#HemeSky #BloodSky #MedSky #podcast
#HemeSky #BloodSky #MedSky #podcast
Reposted by Isabella Presch MD MBA
PSA:
Your period should not
🩸last > 7 days
🩸interfere with your life
🩸happen consistently > than monthly
🩸require product changes more than every 2 hours
🩸have clots larger than a quarter
🩸cause debilitating pain
🩸require double product coverage
🩸make you anemic
You don’t have to suffer.
Your period should not
🩸last > 7 days
🩸interfere with your life
🩸happen consistently > than monthly
🩸require product changes more than every 2 hours
🩸have clots larger than a quarter
🩸cause debilitating pain
🩸require double product coverage
🩸make you anemic
You don’t have to suffer.
July 25, 2025 at 12:45 PM
PSA:
Your period should not
🩸last > 7 days
🩸interfere with your life
🩸happen consistently > than monthly
🩸require product changes more than every 2 hours
🩸have clots larger than a quarter
🩸cause debilitating pain
🩸require double product coverage
🩸make you anemic
You don’t have to suffer.
Your period should not
🩸last > 7 days
🩸interfere with your life
🩸happen consistently > than monthly
🩸require product changes more than every 2 hours
🩸have clots larger than a quarter
🩸cause debilitating pain
🩸require double product coverage
🩸make you anemic
You don’t have to suffer.
Reposted by Isabella Presch MD MBA
Fantastic few days in DC with @ash.hematology.org for media training and the Communications committee meeting.
Fabulous people, incredible food, and inspiring discussions on how we can all continue the important work that’s being done.
Fabulous people, incredible food, and inspiring discussions on how we can all continue the important work that’s being done.
ASH Committee on Communications Summer 2025 meeting complete! Energized to strengthen our Fight4Hematology campaign & advocacy efforts protecting federal funding for hematology research. The future of hematology care depends on continued innovation. #ASH #Fight4Hematology
July 12, 2025 at 1:00 AM
Fantastic few days in DC with @ash.hematology.org for media training and the Communications committee meeting.
Fabulous people, incredible food, and inspiring discussions on how we can all continue the important work that’s being done.
Fabulous people, incredible food, and inspiring discussions on how we can all continue the important work that’s being done.
Reposted by Isabella Presch MD MBA
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Learn more in this Review.
https://ja.ma/4krNDZU
July 5, 2025 at 2:00 PM
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Learn more in this Review.
https://ja.ma/4krNDZU
Reposted by Isabella Presch MD MBA
Women affected by #haemophilia often experience delayed diagnosis. This means not having access to the treatment & care they need, impacting quality of life and putting them at risk of serious bleeding. Time to bust the myth that #women don't have haemophilia. #womenbleedtoo
#HemeSky #BloodSky
#HemeSky #BloodSky
March 13, 2025 at 9:48 AM
Women affected by #haemophilia often experience delayed diagnosis. This means not having access to the treatment & care they need, impacting quality of life and putting them at risk of serious bleeding. Time to bust the myth that #women don't have haemophilia. #womenbleedtoo
#HemeSky #BloodSky
#HemeSky #BloodSky
Reposted by Isabella Presch MD MBA
📚Spotlight on ISTH publications at #ISTH2025:
✅ @rpth.bsky.social: As ISTH’s open-access, online-only journal, RPTH is drives innovation & accessibility in science.
✅ @jthjournal.bsky.social: JTH publishes peer-reviewed groundbreaking research, reviews & clinical guidance
Learn more: bit.ly/4k5PbID
✅ @rpth.bsky.social: As ISTH’s open-access, online-only journal, RPTH is drives innovation & accessibility in science.
✅ @jthjournal.bsky.social: JTH publishes peer-reviewed groundbreaking research, reviews & clinical guidance
Learn more: bit.ly/4k5PbID
Publications Spotlight: JTH & RPTH
ISTH Publications – Research and Practice in Thrombosis and Haemostasis (RPTH)
Research and Practice in Thrombosis and Haemostasis (RPTH) is the open-access, online-only journal of the ISTH. Foll...
bit.ly
June 26, 2025 at 1:31 AM
📚Spotlight on ISTH publications at #ISTH2025:
✅ @rpth.bsky.social: As ISTH’s open-access, online-only journal, RPTH is drives innovation & accessibility in science.
✅ @jthjournal.bsky.social: JTH publishes peer-reviewed groundbreaking research, reviews & clinical guidance
Learn more: bit.ly/4k5PbID
✅ @rpth.bsky.social: As ISTH’s open-access, online-only journal, RPTH is drives innovation & accessibility in science.
✅ @jthjournal.bsky.social: JTH publishes peer-reviewed groundbreaking research, reviews & clinical guidance
Learn more: bit.ly/4k5PbID
Reposted by Isabella Presch MD MBA
What an inspiring #ISTH2025!
It was wonderful to host the global #thrombosis & #hemostasis community in DC.
From the latest science & innovations to networking & building new collabs - it had it all!
Look out for recordings & other post- @isth.org congress updates.
Goodbye & see you @ #ISTH2026!
It was wonderful to host the global #thrombosis & #hemostasis community in DC.
From the latest science & innovations to networking & building new collabs - it had it all!
Look out for recordings & other post- @isth.org congress updates.
Goodbye & see you @ #ISTH2026!
June 25, 2025 at 7:37 PM
What an inspiring #ISTH2025!
It was wonderful to host the global #thrombosis & #hemostasis community in DC.
From the latest science & innovations to networking & building new collabs - it had it all!
Look out for recordings & other post- @isth.org congress updates.
Goodbye & see you @ #ISTH2026!
It was wonderful to host the global #thrombosis & #hemostasis community in DC.
From the latest science & innovations to networking & building new collabs - it had it all!
Look out for recordings & other post- @isth.org congress updates.
Goodbye & see you @ #ISTH2026!
Last day of another fantastic #ISTH2025 #science #innovation #clinicalresearch #thrombosis #hemostasis
Looking forward to #ISTH2026 in Paris
Looking forward to #ISTH2026 in Paris
June 25, 2025 at 1:22 PM
Last day of another fantastic #ISTH2025 #science #innovation #clinicalresearch #thrombosis #hemostasis
Looking forward to #ISTH2026 in Paris
Looking forward to #ISTH2026 in Paris
Last day starts with an
Inspiring presentation @rkaczmarekdr.bsky.social #ISTH2025 #hemophilia #genetherapy #Toleranceinduction
Will gene therapy be used for tolerance induction in future?
Inspiring presentation @rkaczmarekdr.bsky.social #ISTH2025 #hemophilia #genetherapy #Toleranceinduction
Will gene therapy be used for tolerance induction in future?
June 25, 2025 at 1:18 PM
Last day starts with an
Inspiring presentation @rkaczmarekdr.bsky.social #ISTH2025 #hemophilia #genetherapy #Toleranceinduction
Will gene therapy be used for tolerance induction in future?
Inspiring presentation @rkaczmarekdr.bsky.social #ISTH2025 #hemophilia #genetherapy #Toleranceinduction
Will gene therapy be used for tolerance induction in future?
Joint Session on VWD & women’s health issues in #thrombosis and #hemostasis Gynecological bleeding and management in women with VWD #ISTH2025 #hematology #gynecology Dr Ozlem Turan, Royal Free Hospital NHS
June 24, 2025 at 10:34 PM
Joint Session on VWD & women’s health issues in #thrombosis and #hemostasis Gynecological bleeding and management in women with VWD #ISTH2025 #hematology #gynecology Dr Ozlem Turan, Royal Free Hospital NHS
